Evaluation of Efficacity and Safety of Oseltamivir and Zanamivir (BIVIR)
This study has been terminated.
(Just Terminated for the end of the pandemia)
Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
Hoffmann-La Roche
GlaxoSmithKline
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00799760
First received: November 28, 2008
Last updated: March 16, 2012
Last verified: November 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):